A Randomized, Single-Blind Study Evaluating the Effect of a Bone Pain Education Video on Reported Bone Pain in Patients with Breast Cancer Receiving Chemotherapy and Pegfilgrastim
Background: Mild-to-moderate bone pain is the most commonly reported adverse event associated with pegfilgrastim. Aims: To investigate the effect of bone pain education on pegfilgrastim-related bone pain in patients with breast cancer receiving chemotherapy and pegfilgrastim. Design: Randomized, single-blind study. Settings: Forty-eight community oncology clinics throughout the United States. Participants: Three hundred women ≥18 years of age with newly diagnosed stage I -III breast cancer, who were planning ≥4 cycles of neoadjuvant or adjuvant chemotherapy with pegfilgrastim support starting in cycle 1.
Source: Pain Management Nursing - Category: Nursing Authors: Andrew S. Guinigundo, Cathy L. Maxwell, Linda Vanni, Phuong Khanh Morrow, Maureen Reiner, Alex Shih, Zandra Klippel, Elizabeth Blanchard Tags: Original Article Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Education | Eyes | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nurses | Nursing | Pain | Pain Management | Study | Universities & Medical Training | USA Health | Women